Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
MIAMI/NEW YORK - Securitize, Inc. announced Thursday it has confidentially submitted a draft registration statement on Form S-4 to the Securities and Exchange Commission through its wholly-owned subsidiary, Securitize Holdings, Inc.
The filing relates to Securitize’s previously announced business combination with Cantor Equity Partners II, Inc. (NASDAQ:CEPT), a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald. CEPT currently trades at $11.26 with a market capitalization of $344.33 million. Upon completion of the proposed transaction, the combined company will be renamed Securitize Corp. and is expected to trade on Nasdaq under the ticker symbol "SECZ."
The draft registration was submitted on Wednesday, according to the press release statement.
"The confidential submission of our S-4 marks another important milestone toward bringing tokenization to the public markets," said Carlos Domingo, Co-Founder and Chief Executive Officer of Securitize.
Securitize describes itself as a platform for tokenizing real-world assets with over $4 billion in assets under management through tokenized funds and equities. The company operates as an SEC-registered broker dealer, digital transfer agent, fund administrator, and operator of an SEC-regulated Alternative Trading System.
The completion of the proposed transaction remains subject to customary closing conditions, including approval from CEPT shareholders and the effectiveness of the registration statement. InvestingPro data shows CEPT is profitable with earnings of $0.15 per share over the last twelve months, though it’s currently trading at a high P/E ratio of 72.76.
Cantor Equity Partners II is led by Chairman and Chief Executive Officer Brandon Lutnick. Its parent company, Cantor Fitzgerald L.P., employs more than 14,000 people and provides various financial services including investment banking, asset management, and brokerage. According to InvestingPro analysis, CEPT appears overvalued compared to its Fair Value estimate and has a "WEAK" financial health rating, though it maintains strong liquidity with a current ratio of 3.08.
The press release noted that investors should consult the registration statement once it becomes publicly available for detailed information about the proposed transaction. Investors seeking deeper analysis of CEPT’s financial position ahead of this merger can access additional InvestingPro tips and metrics, including valuation models and comprehensive financial health assessments that could prove valuable when evaluating this SPAC transaction. Check out the most overvalued stocks list for context on CEPT’s current market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.